Next 10 |
2024-02-01 16:02:50 ET Summary Revolution Medicines, Inc. has interesting science and early positive data. However, their market cap is too high for a company such as Revolution Medicines. Their R&D expenses are very high. The EQRx, Inc. deal is highly interesting, but...
2023-11-14 16:01:42 ET More on EQRx, Globalstar, etc. Globalstar: The Positives And Negatives Weigh Into A Hold Rating Revolution Medicines: A March Halted By 'Lackluster' ESMO Readout SoftBank Group Corp. (SFTBY) Q2 2023 Earnings Call Transcript Revolu...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
2023-11-08 12:15:59 ET More on EQRx, Revolution Medicines, etc. Revolution Medicines: A Big Pipeline In Need Of Big Data Revolution Medicines falls after early-stage data for cancer therapy Why did Revolution Medicines stock go up? Encouraging data for two drug...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. (Nasdaq: EQRX), announced that earlier today, at their respective specia...
2023-11-03 15:00:40 ET More on the markets SPY: From Bullish To Bearish - Why The Bears Could Be Right This Time (Rating Downgrade) My View Of The S&P 500 November 2023 Edition (Technical Analysis) Famous Chart Pattern Returns To Life Six bullish stocks t...
NEW YORK, NY / ACCESSWIRE / October 20, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc. ("CM Life Sciences"), which was acquired by EQRx, Inc. ("EQRx") (NASDAQ:EQRX) on August 5, 2021. Investors who purchased CM...
2023-10-17 14:18:15 ET Are you looking for the best penny stocks to buy now ? Today might be your day…or not. These high-flying, low-priced stocks are well known for their innate ability to explode within a matter of minutes at times. Imagine seeing a stock that trades for pe...
2023-09-25 15:24:12 ET Summary Revolution Medicines, Inc. has a diversified pipeline of drugs but is still searching for its flagship project, making it a high-risk investment. The company is focusing on developing RAS(ON) inhibitors, which target the active form of KRAS, with sev...
NEW YORK, NY / ACCESSWIRE / August 20, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: New Relic, Inc. (NYSE:NEWR)'s sal...
News, Short Squeeze, Breakout and More Instantly...
EQRx Inc. Company Name:
EQRX Stock Symbol:
NASDAQ Market:
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. (Nasdaq: EQRX), announced that earlier today, at their respective specia...